HDA Media And Political Bulletin – 23 November 2016
|House of Commons Questions;
Nigel Adams tabled a question on the Pharmacy Integration Fund which was answered by the Pharmacy Minister, David Mowat, on 21 November 2016.
Crispin Blunt tabled a question in regards to the Pharmaceutical Price Regulation Scheme. This was answered on 21 November 2016 by Nicola Blackwood from the Department of Health.
|House of Commons Questions, Pharmacy, 21 November 2016
Nigel Adams: If his Department will bring forward a community pharmacy (a) campaign and (b) audit on unwanted medicines.
Department of Health
The Pharmaceutical Services Negotiating Committee (PSNC) put forward a range of service development and counter proposals during the course of the consultation with them on community pharmacy in 2016/17 and beyond. These proposals were all given full consideration by the Department. The final package contained two of the PSNC’s counter proposals – the proposal to introduce a quality payment, and the proposal for an urgent supply of medicines scheme.
The independent review being conducted by Richard Murray, of the King’s Fund, will consider what clinical services should be provided by community pharmacy in the future, and how they should be commissioned.
The Pharmacy Integration Fund will be used to commission and evaluate activities that bring about clinical pharmacy integration within the National Health Service demonstrating improvements in health outcomes for patients and the public in primary care and in the community.
House of Commons Questions, Pharmaceutical Price Regulation Scheme, 21 November 2016
Crispin Blunt: What discussions he has had on enhancing consultation with stakeholders on the Pharmaceutical Price Regulation in the preparation and conduct of the forthcoming negotiations on the next such Scheme, in particular with industry bodies representing companies directly affected through their participation in the Scheme.
Department of Health
We have not had any discussions relating to a successor to the current five-year Pharmaceutical Price Regulation Scheme, which came into effect on 1 January 2014.
|There is no media coverage today.|
From Factory to Pharmacy
As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.See the Infographic
Apply to become a Member
Membership of the HDA guarantees your organisation:
- Access to leading policy and industry forums of debate and discussion
- Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
- Representation on HDA working parties, including the Members’ Liaison Group
- A daily Political and Media Bulletin and HDA Newsletters
- Access to HDA policy documents and all sections of the HDA website
- Branding and marketing opportunities